Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
China · Delayed Price · Currency is CNY 4.880
+0.050 (1.04%)
Aug 4, 2026, 3:04 PM CST
SHE:300318 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,986 | 5,122 | 4,673 | 5,097 | 4,779 | 8,095 | |
Market Cap Growth | -24.46% | 9.62% | -8.33% | 6.67% | -40.97% | -17.14% |
Enterprise Value | 5,660 | 7,088 | 6,550 | 6,751 | 6,424 | 8,685 |
Last Close Price | 4.88 | 6.27 | 5.72 | 6.24 | 5.85 | 9.91 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 505.37 | - | - | - |
Forward PE | - | 61.83 | 61.83 | 61.83 | 61.83 | 61.83 |
PS Ratio | 4.90 | 6.21 | 5.49 | 4.88 | 6.00 | 11.33 |
PB Ratio | 1.84 | 2.35 | 1.99 | 2.18 | 2.06 | 8.68 |
P/TBV Ratio | 33.84 | 41.30 | 19.01 | 17.83 | 16.11 | - |
P/OCF Ratio | - | - | - | 37.20 | 117.36 | 9118.86 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 6.96 | 8.60 | 7.69 | 6.46 | 8.07 | 12.15 |
EV/EBITDA Ratio | 103.63 | 130.12 | 41.67 | 42.53 | 983.61 | - |
EV/EBIT Ratio | - | - | 104.20 | 114.49 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.43 | 0.52 | 0.45 | 0.35 | 0.34 | 0.59 |
Debt / EBITDA Ratio | 16.98 | 17.43 | 6.31 | 4.70 | 77.22 | - |
Net Debt / Equity Ratio | 0.36 | 0.46 | 0.42 | 0.30 | 0.29 | 0.55 |
Net Debt / EBITDA Ratio | 17.63 | 18.42 | 6.20 | 4.42 | 103.25 | -72.41 |
Net Debt / FCF Ratio | -2.66 | -3.43 | -4.28 | -11.60 | -5.59 | -1.40 |
Asset Turnover | 0.19 | 0.20 | 0.21 | 0.27 | 0.21 | 0.19 |
Inventory Turnover | 0.49 | 0.49 | 0.47 | 0.69 | 0.64 | 0.52 |
Quick Ratio | 0.16 | 0.18 | 0.17 | 0.24 | 0.23 | 0.10 |
Current Ratio | 0.94 | 0.93 | 1.01 | 1.06 | 1.01 | 0.43 |
Return on Equity (ROE) | -8.00% | -7.60% | 0.37% | 0.67% | -8.49% | -42.65% |
Return on Assets (ROA) | -0.60% | -0.50% | 0.98% | 0.94% | -1.63% | -1.89% |
Return on Invested Capital (ROIC) | -1.36% | -1.03% | 0.86% | 0.91% | -4.46% | -6.48% |
Return on Capital Employed (ROCE) | -1.50% | -1.20% | 2.20% | 2.10% | -3.60% | -9.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -2.39% | -1.80% | 0.20% | -0.49% | -1.64% | -3.98% |
FCF Yield | -7.40% | -5.70% | -4.87% | -1.19% | -2.53% | -4.52% |
Payout Ratio | - | - | 353.23% | - | - | - |
Buyback Yield / Dilution | -0.30% | 0.14% | -0.11% | -0.03% | -0.03% | -0.15% |
Total Shareholder Return | -0.30% | 0.14% | -0.11% | -0.03% | -0.03% | -0.15% |